Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question

Bibliographic Details
Main Author:	Hyun Woong Lee
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2014-12-01
Series:	Clinical and Molecular Hepatology
Online Access:	http://e-cmh.org/upload/pdf/cmh-20-345.pdf

Similar Items

Use of angiotensin receptor blockers for the treatment of hypertension in India
by: H.S. Malhi
Published: (2014-11-01)

Place of angiotensin receptor blockers in antihypertensive therapy
by: A I Martynov, et al.
Published: (2014-03-01)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
by: John D Bisognano, et al.
Published: (2007-11-01)

The use of angiotensin receptor blockers in dementia prevention
by: Jordana de Araujo Müller, et al.
Published: (2023-09-01)

Angiotensin receptor blockers in heart failure
by: Jan Östergren, et al.
Published: (2003-09-01)

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)

Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus
by: M.D. Ivanova, et al.
Published: (2015-04-01)

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: D. V. Nebieridze
Published: (2002-02-01)

Potential use of angiotensin receptor blockers in skin pathologies
by: Keshvad Hedayatyanfard, et al.
Published: (2023-07-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
by: Graham J. Moore, et al.
Published: (2021-07-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

Combined effects of angiotensin receptor blocker use and physical training in hypertensive men
by: Tábata de Paula Facioli, et al.
Published: (2022-05-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Prescription Pattern and Costs of Angiotensin II Receptor Blockers in Hypertensive Outpatients
by: Nurmainah Nurmainah, et al.
Published: (2018-12-01)

Long-term use of angiotensin receptor blockers and the risk of cancer.
by: Laurent Azoulay, et al.
Published: (2012-01-01)

Angiotensin receptor blocker selectivity at the AT- and AT-receptors: conceptual and clinical effects
by: Thomas Unger, et al.
Published: (2000-06-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Review: The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors
by: Domenic A Sica
Published: (2002-06-01)

Clinical pharmacology of angiotensin II receptor blockers: valsartan
by: M. V. Leonova
Published: (2014-12-01)

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01)

Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
by: Prakash C Deedwania, et al.
Published: (2006-03-01)

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01)

Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
by: Prakash C Deedwania, et al.
Published: (2006-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
by: Hany A Al-Hussaniy, et al.
Published: (2023-01-01)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
by: Guy Salama
Published: (2022-08-01)

Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion
by: Kanika Aggarwal, et al.
Published: (2020-01-01)

An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
by: Garaga Srinivas, et al.
Published: (2015-06-01)

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
by: Ram CV
Published: (2011-05-01)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
by: Amer Harky, et al.
Published: (2021-01-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
by: Ji-Guang Wang
Published: (2009-07-01)

Rationale for angiotensin II receptor blocker therapy in chronic heart failure
by: Jay N Cohn
Published: (2000-06-01)

Rationale for angiotensin II receptor blocker therapy in chronic heart failure
by: Jay N Cohn
Published: (2000-06-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Critical review of cancer risk associated with angiotensin receptor blocker therapy
by: Waeber B, et al.
Published: (2011-12-01)

Evidence-based treatment of hypertension: What's the role of angiotensin II receptor blockers?
by: Hobbs, R, et al.
Published: (2005)

Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
by: I V Butorov, et al.
Published: (2004-06-01)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
by: Heirim Lee, et al.
Published: (2022-10-01)

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
by: David S. Fedson, et al.
Published: (2016-03-01)

Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01)